Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 8, 2026, 1:23 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 2281–2304 of 17,766 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Control Population Clear all

Conditions: PreDiabetes
Interventions: Avocado, low fat yogurt, low fat yogurt + fiber +fat; Other
Lead sponsor: Clinical Nutrition Research Center, Illinois Institute of Technology; Industry
Eligibility: 25 Years to 70 Years
Enrollment: 50 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2025
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Osteoarthritis
Interventions: OA-PCP Intervention, Attention Control; Behavioral
Lead sponsor: University of North Carolina, Chapel Hill; Other
Eligibility: 65 Years and older
Enrollment: 240 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2023
U.S. locations: 1
States / cities: Chapel Hill, North Carolina

Conditions: Brain and Central Nervous System Tumors, Musculoskeletal Complications
Interventions: testosterone gel applied to skin, whey powder protein; Drug · Dietary Supplement
Lead sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; Other
Eligibility: 18 Years to 120 Years · Male only
Enrollment: 1 participant
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Pneumonia
Interventions: Amikacin (BAY41-6551), Placebo; Drug
Lead sponsor: Bayer; Industry
Eligibility: 18 Years and older
Enrollment: 69 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2006
U.S. locations: 7
States / cities: Birmingham, Alabama • Melbourne, Florida • Albany, New York + 4 more

Conditions: Diabetes, Breast Cancer
Interventions: Integrated Intervention for Breast Cancer Survivors with Diabetes, Attention Control; Behavioral
Lead sponsor: Icahn School of Medicine at Mount Sinai; Other
Eligibility: 55 Years and older · Female only
Enrollment: 59 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2023
U.S. locations: 3
States / cities: Chicago, Illinois • New Hyde Park, New York • New York, New York

Conditions: Cancer Prevention, Dietary Guidelines
Interventions: Eatwell, Nutrition Education Control Group; Behavioral · Other
Lead sponsor: Drexel University; Other
Eligibility: 18 Years and older
Enrollment: 472 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2030
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Diabetic Retinopathy, Diabetic Macular Edema
Interventions: Financial Incentive, Retinal Care DR; Behavioral
Lead sponsor: Retinal Care Inc.; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 4,500 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2023
U.S. locations: 1
States / cities: Oklahoma City, Oklahoma

Conditions: Pulmonary Disease, Chronic Obstructive
Interventions: Placebo ELLIPTA, Nemiralisib ELLIPTA 50 µg, Nemiralisib ELLIPTA 100 µg, Nemiralisib ELLIPTA 250 µg, Nemiralisib ELLIPTA 500 µg, Nemiralisib ELLIPTA 750 µg, Albuterol (Salbutamol) MDI or nebules, Standard of care therapy; Drug
Lead sponsor: GlaxoSmithKline; Industry
Eligibility: 40 Years to 80 Years
Enrollment: 943 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 21
States / cities: Mobile, Alabama • Colorado Springs, Colorado • Daytona Beach, Florida + 17 more

Conditions: Osteoarthritis of the Knee
Interventions: X0002, Placebo; Drug
Lead sponsor: Lina Xu; Industry
Eligibility: 35 Years to 85 Years
Enrollment: 216 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2016
U.S. locations: 20
States / cities: Tempe, Arizona • Carmichael, California • Spring Valley, California + 17 more

Conditions: Secondary Traumatic Stress
Interventions: Resiliance Alliance, Secondary traumatic stress training; Behavioral
Lead sponsor: NYU Langone Health; Other
Eligibility: 18 Years and older
Enrollment: 357 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2012
U.S. locations: 4
States / cities: Brooklyn, New York • New York, New York • Staten Island, New York + 1 more

Conditions: Atrial Fibrillation
Interventions: Esophageal Cooling, Control; Device
Lead sponsor: University of Pennsylvania; Other
Eligibility: 18 Years and older
Enrollment: 55 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2021
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Intubation Complication
Interventions: Budesonide and Azithromycin, Placebo control of budesonide and azithromycin; Drug · Other
Lead sponsor: Vanderbilt University Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 64 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2026
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Post-Traumatic Stress Disorder
Interventions: BI 1358894, Placebo; Drug
Lead sponsor: Boehringer Ingelheim; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 318 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 37
States / cities: Little Rock, Arkansas • Glendale, California • Long Beach, California + 31 more

Conditions: Type 2 Diabetes
Interventions: Education and patient liaison combination, Control group; Behavioral
Lead sponsor: Meharry Medical College; Other
Eligibility: 21 Years and older · Female only
Enrollment: 56 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2014
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Menopause, Hypertension
Interventions: Taekwondo training; Behavioral
Lead sponsor: Kosin University; Other
Eligibility: 65 Years to 85 Years · Female only
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: Omaha, Nebraska

Conditions: Stroke, Acute
Interventions: BrainPulse Device; Device
Lead sponsor: Jan Medical, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 252 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2024
U.S. locations: 3
States / cities: Arlington Heights, Illinois • Evanston, Illinois • Cincinnati, Ohio

Conditions: Nicotine Dependence
Interventions: Bupropion SR, Nicotine Patch, Placebo Patch and Placebo Pill; Drug
Lead sponsor: Southern Illinois University Carbondale; Other
Eligibility: 18 Years to 55 Years
Enrollment: 197 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2013
U.S. locations: 1
States / cities: Carbondale, Illinois

Conditions: Virus, HSV-1, Herpes Simplex 1, Herpes Simplex Labialis
Interventions: Purell Hand Sanitizer, Medical Grade Mineral Oil; Drug
Lead sponsor: Leciel Bono; Other
Eligibility: 18 Years to 99 Years
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2023
U.S. locations: 3
States / cities: Pocatello, Idaho • St. George, Utah

Conditions: Social Anxiety Disorder
Interventions: Group Cognitive Behavioral Therapy, Yohimbine Hydrochloride, Sugar Pill; Behavioral · Drug
Lead sponsor: Southern Methodist University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009 – 2013
U.S. locations: 2
States / cities: Boston, Massachusetts • Dallas, Texas

Conditions: Plasmodium Falciparum Infection
Interventions: Chloroquine, PfSPZ (NF54) Challenge, Placebo; Drug · Biological · Other
Lead sponsor: National Institute of Allergy and Infectious Diseases (NIAID); NIH
Eligibility: 18 Years to 45 Years
Enrollment: 28 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Healthy, Chronic Kidney Diseases
Interventions: Definity, Super-resolution ultrasound imaging; Drug · Diagnostic Test
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older
Enrollment: 186 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2028
U.S. locations: 2
States / cities: Jacksonville, Florida • Rochester, Minnesota

Conditions: Maternal Depression, Parenting Behavior, Health, Interpersonal Relationships, Goal Directed Behavior, Child Behavior, Child School Readiness
Interventions: Interpersonal Psychotherapy for Depression -Group; Behavioral
Lead sponsor: University of Southern California; Other
Eligibility: Female only
Enrollment: 208 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2018
U.S. locations: 2
States / cities: Los Angeles, California

Conditions: Physical Activity
Interventions: Intervention; Behavioral
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 18 Years and older
Enrollment: 1,241 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2022
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Bradycardia, Slow Heart Beat
Interventions: Implantable Pulse Generator (IPG) and Pacing Leads (wires), Magnetic Resonance Imaging (MRI) scan; Device · Other
Lead sponsor: Medtronic Cardiac Rhythm and Heart Failure; Industry
Eligibility: Not listed
Enrollment: 484 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2010
U.S. locations: 15
States / cities: Redwood City, California • Salinas, California • Orlando, Florida + 12 more

Search by objective public record fields.

Avocado Snacks in a Prediabetic Population

Physical Activity Pathway for Patients With Osteoarthritis in Primary Care (OA-PCP) (R33)

Testosterone Gel in Preventing Weakness Caused by Steroid Therapy in Men With Glioma

A Study to Determine the Correct Dose of Amikacin Which is Delivered Directly to the Lungs of Ventilated Patients as an Aerosol Via an Investigational Device Called the Pulmonary Delivery Device System (PDDS)

Integrated Intervention for Breast Cancer Survivors With Diabetes

Eatwell Clinical Trial (R01)

PROTECT2: Diabetes Care - Eye Exam

Dose Finding Study of Nemiralisib (GSK2269557) in Subjects With an Acute Moderate or Severe Exacerbation of Chronic Obstructive Pulmonary Disease (COPD)

A Study to Evaluate the Efficacy and Safety of X0002 Spray in Subjects With Osteoarthritis

The Resilience Alliance

Esophageal Cooling for AF Ablation

Incidence of Acute Laryngeal Injury Following Endotracheal Intubation

A Study to Test Whether Taking BI 1358894 for 8 Weeks Helps Adults With Post-traumatic Stress Disorder

Type 2 Diabetes Self-management Intervention for Low-income Women

Taekwondo Training and Postmenopausal Women With Stage-2 Hypertension

Pilot Study of Acute Stroke Using the Brainpulse™

Nicotine Replacement Therapy (NRT) and Bupropion Mechanisms of Effectiveness in Smokers

Hand Sanitizer Use for Herpes Simplex Virus-1

Yohimbine to Enhance Cognitive Behavioral Therapy (CBT) for Social Anxiety

PfSPZ Challenge in Healthy Malaria-Naïve Adults in the United States

A Study of Renal Microvessel Imaging for Chronic Kidney Disease

Healthy Moms-Healthy Kids: Reducing Maternal Depression for Better Outcomes in Head Start Children

Promoting Physical Activity in Rural Communities

EMRI SureScan™ Clinical Study